- Forbes, Friday, April 5, 2013 10 AM
A federal appeals court in Massachusetts reversed a lower court's decision to throw out a lawsuit by Aetna. The suit accused Pfizer of illegally promoting the off-label use of Neurontin. The First
Circuit Court of Appeals ruled that a lower court erred when it refused to allow Aetna to sue Pfizer over what it called a racketeering conspiracy to induce physicians to prescribe Neurontin for off-label uses like treating
bipolar disorder.
Read the whole story at Forbes »